IRIS
VERITTI, Daniele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.025
AS - Asia 3.311
EU - Europa 1.820
SA - Sud America 648
Continente sconosciuto - Info sul continente non disponibili 328
AF - Africa 70
OC - Oceania 7
Totale 13.209
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.886
SG - Singapore 1.674
CN - Cina 593
BR - Brasile 510
IT - Italia 448
UA - Ucraina 326
HK - Hong Kong 310
VN - Vietnam 277
DE - Germania 226
RU - Federazione Russa 181
FR - Francia 142
BD - Bangladesh 125
FI - Finlandia 120
IE - Irlanda 89
GB - Regno Unito 83
CA - Canada 79
TR - Turchia 78
IN - India 75
SE - Svezia 66
AR - Argentina 52
NL - Olanda 34
KR - Corea 27
EC - Ecuador 25
AT - Austria 24
MX - Messico 23
JP - Giappone 21
ZA - Sudafrica 21
ID - Indonesia 20
IQ - Iraq 20
PL - Polonia 19
BE - Belgio 18
CO - Colombia 18
PK - Pakistan 16
PY - Paraguay 11
ES - Italia 10
MA - Marocco 10
CL - Cile 9
KE - Kenya 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
PE - Perù 8
CR - Costa Rica 7
VE - Venezuela 7
EG - Egitto 6
HN - Honduras 6
JM - Giamaica 6
TG - Togo 6
AZ - Azerbaigian 5
CH - Svizzera 5
OM - Oman 5
PH - Filippine 5
PT - Portogallo 5
TN - Tunisia 5
AU - Australia 4
JO - Giordania 4
KG - Kirghizistan 4
LT - Lituania 4
MY - Malesia 4
RO - Romania 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
IR - Iran 3
KZ - Kazakistan 3
PS - Palestinian Territory 3
TH - Thailandia 3
UY - Uruguay 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
HU - Ungheria 2
IL - Israele 2
LU - Lussemburgo 2
NI - Nicaragua 2
NP - Nepal 2
PR - Porto Rico 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
GL - Groenlandia 1
GT - Guatemala 1
IS - Islanda 1
KH - Cambogia 1
LB - Libano 1
Totale 12.868
Salva come PNG Salva come JPEG
Città #
Woodbridge 668
Singapore 625
Ashburn 624
Fairfield 622
Ann Arbor 468
Houston 440
Chandler 429
Beijing 313
Hong Kong 303
Seattle 251
Council Bluffs 245
San Jose 242
Wilmington 240
Cambridge 189
Jacksonville 188
Boardman 159
Dearborn 132
Lauterbourg 112
Princeton 94
Los Angeles 92
Dublin 89
Ho Chi Minh City 85
Izmir 68
Dallas 64
New York 62
Udine 60
Elk Grove Village 58
Santa Clara 58
Redondo Beach 49
Buffalo 47
Hanoi 46
San Diego 39
Milan 35
Munich 35
São Paulo 34
Hefei 33
Ogden 29
Norwalk 26
Phoenix 26
Seoul 26
The Dalles 26
Chicago 25
Des Moines 24
Falls Church 23
Belluno 21
Helsinki 21
Ottawa 21
Dong Ket 20
Frankfurt am Main 19
Mumbai 18
Porto Alegre 18
Rome 18
Toronto 18
Warsaw 18
Belo Horizonte 17
Brussels 17
Brooklyn 15
Martellago 15
Rio de Janeiro 15
Düsseldorf 14
Grafing 14
Montreal 14
Orem 14
Stockholm 14
Atlanta 13
Bologna 12
Denver 12
San Francisco 12
Amsterdam 11
Quito 11
Chennai 10
Johannesburg 10
London 10
Nuremberg 10
Tokyo 10
Treviso 10
Vienna 10
Brasília 9
Haiphong 9
Lappeenranta 9
Manchester 9
Mexico City 9
Nanjing 9
Redmond 9
Turin 9
Biên Hòa 8
Da Nang 8
Jinan 8
Milwaukee 8
Naples 8
Tashkent 8
Wuhan 8
Baghdad 7
Boston 7
Guangzhou 7
Kunming 7
Nairobi 7
Newark 7
Paese 7
Shanghai 7
Totale 8.169
Salva come PNG Salva come JPEG
Nome #
Triamcinolone acetonide for the treatment of diabetic macular oedema 224
A case of CRB1-negative Coats-like retinitis pigmentosa 193
Intravitreal aflibercept for choroidal neovascularization due to age-related macular degeneration unresponsive to ranibizumab therapy 187
Advances in pharmacotherapy for wet age-related macular degeneration 185
Neovascular age-related macular degeneration 180
Bevacizumab and triamcinolone acetonide for choroidal neovascularization due to age-related macular degeneration unresponsive to antivascular endothelial growth factors 175
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular oedema: Six-month outcomes of the UDBASA study 169
Fluocinolone acetonide for the treatment of diabetic macular edema 169
Dexamethasone implant in diabetic macular edema in real-life situations 168
Effects of VEGF inhibition on retinal morphology, neovascular network size, and visual acuity in patients with vascularized pigment epithelium detachment because of occult choroidal neovascularization. 168
Proliferative Diabetic Retinopathy: Treatment Update 168
Online optical coherence tomography during subthreshold laser irradiation 164
Low-concentration infracyanine green-assisted internal limiting membrane peeling in idiopathic macular pucker 25-gauge surgery 162
Major ocular complications after organ transplantation 162
Optimal Keratoplasty for the Correction of Presbyopia and Hypermetropia 157
Selective laser trabeculoplasty 155
Author’s response 155
One-year results of aflibercept in vascularized pigment epithelium detachment due to neovascular AMD: A prospective study 155
Pharmacotherapy for treatment of retinal vein occlusion. 154
Optical coherence tomography angiography findings in diabetic retinopathy 153
Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes 153
Triple therapy for corneal neovascularization: A case report 152
One-year outcome of ranibizumab for neovascular age-related macular degeneration: a thorough analysis in a real-world clinical setting. 151
Intravitreal injections: a healthcare failure modes and effects analysis. 148
Non-proliferative diabetic retinopathy 147
Fundus autofluorescence applications in retinal imaging 146
New advances in retina: A report from the International Symposium on Ocular Pharmacology and Therapeutics meeting 145
Early Effects of Dexamethasone Implant on Macular Morphology and Visual Function in Patients with Diabetic Macular Edema 143
Delayed rhegmatogenous retinal detachment post macular surgery - a multicentric study 142
Ocular complications after hand transplantation 140
Update on combination therapy in wet age-related macular degeneration 138
Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: One-year follow-up 137
Diabetic macular edema 136
Triple therapy for anti-vascular endothelial growth factor nonresponders in neovascular age-related macular degeneration: Impact of different photodynamic therapy parameters 136
The effect of triamcinolone acetonide, sodium hyaluronate, and chondroitin sulfate on human endothelial cells: An in vitro study 136
Functional and morphological changes after macular pucker surgery: An optical coherence tomography and microperimetric study 133
A Propensity-Score Matching Comparison between 27-Gauge and 25-Gauge Vitrectomy Systems for the Repair of Primary Rhegmatogenous Retinal Detachment 133
A comparison between a white LED confocal imaging system and a conventional flash fundus camera using chromaticity analysis 133
Different antivascular endothelial growth factor treatments and regimens and their outcomes in neovascular age-related macular degeneration: A literature review 131
Early effects of dexamethasone implant on macular morphology and visual function in patients with macular edema secondary to retinal vein occlusion. 130
Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study 130
Early intraocular pressure dynamics following aflibercept 8 mg versus aflibercept 2 mg: a propensity score-matched analysis 129
Drug safety evaluation of intravitreal triamcinolone acetonide 129
Macular pucker 127
Infection control measures in ophthalmology during the COVID-19 outbreak: A narrative review from an early experience in Italy 125
Pharmacotherapeutic management of macular edema in diabetic subjects undergoing cataract surgery 124
Faricimab in Neovascular AMD Complicated by Pigment Epithelium Detachment: An AI-Assisted Evaluation of Early Morphological Changes 122
The Present and Future of Optic Pathway Glioma Therapy 122
Intravitreal steroids for the treatment of retinal diseases. 121
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome 121
Dexamethasone Implant Produces Better Outcomes than Oral Acetazolamide in Patients with Cystoid Macular Edema Secondary to Retinitis Pigmentosa 119
Experience with the Pascal® photocoagulator: An analysis of over 1200 laser procedures with regard to parameter refinement 117
Regression of diabetic macular edema after subcutaneous exenatide. 116
Scleral fixation of a single-piece foldable acrylic IOL through a 1.80 mm corneal incision 116
Surgical Management for Diabetic Macular Edema 112
Anti-VEGF Drugs Dynamics: Relevance for Clinical Practice 112
Steroids in a Combination Strategy 110
Dexamethasone implant with fixed or individualized regimen in the treatment of diabetic macular edema: the UDBASA study 110
Ocular Findings in {COVID}-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye 109
Trauma and emergencies 106
Color fundus autofluorescence to determine activity of macular neovascularization in age-related macular degeneration 104
Vitrectomy in Small idiopathic MAcuLar hoLe (SMALL) study: conventional internal limiting membrane peeling versus inverted flap 102
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 102
Vascular Anomalies of the Fundus Oculi: Diagnosis and Treatment 101
Combination Therapy for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Anti-VEGF Monotherapy. Intravitreal Bevacizumab and Triamcinolone Acetonide 100
Diabetic macular edema 98
Choriocapillaris and outer choroid blood flow in acute central serous chorioretinopathy: a swept source OCT angiography study 94
Automated diabetic retinopathy detection with two different retinal imaging devices using artificial intelligence: a comparison study 93
Behind the mask: a critical perspective on the ethical, moral, and legal implications of AI in ophthalmology 88
Intraocular pressure (IOP) after intravitreal dexamethasone implant (Ozurdex) amongst different geographic populations—GEODEX-IOP study 88
Edema maculare post occlusione venosa 88
Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers 87
null 85
Impact on quality of life 85
Occhio 84
Chromaticity analysis comparing a white light confocal imaging device versus a flash fundus camera 83
Managing Neovascular Age-Related Macular Degeneration in Clinical Practice: Systematic Review, Meta-Analysis, and Meta-Regression 83
Effects of antithrombotic agents on ophthalmological outcomes, cardiovascular risk, and mortality in hypertensive patients with retinal vein occlusion: An exploratory retrospective study 82
Stem cell therapy in retinal diseases: current evidence 81
Validation of Esaso Classification of Diabetic Maculopathy 80
Present Status of Laser Therapy: Role of Subthreshold Laser 79
Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study 78
Pharmacokinetic and Pharmacodynamic Rationale for Extending VEGF Inhibition Increasing Intravitreal Aflibercept Dose 77
Subthreshold laser 76
Vitrectomy in Small idiopathic MAcuLar hoLe (SMALL) study: Internal limiting membrane peeling versus no peeling 75
The role of steroids in the treatment of diabetic macular edema 74
Managing diabetic macular edema in clinical practice: systematic review and meta-analysis of current strategies and treatment options 74
Multimodal imaging in diabetic retinopathy and macular edema: An update about biomarkers 74
Enhancing Diabetic Macular Edema Treatment Outcomes: Exploring the ESASO Classification and Structural OCT Biomarkers 73
Update on coronavirus disease 2019: Ophthalmic Manifestations and Adverse Reactions to Vaccination 72
Explainable artificial intelligence model for the detection of geographic atrophy using colour retinal photographs 71
Management of treatment-naïve diabetic macular edema patients: Review of real-world clinical data 71
One-year efficacy of anti-vascular endothelial growth factor agents in patients with neovascular age-related macular degeneration: a meta-analysis and meta-regression 71
Intravitreal Bevacizumab for Choroidal Neovascularization due to Pathological Myopia: Long-term Outcomes 67
Macular Holes 66
Twelve months outcomes of Intravitreal aflibercept for neovascular age-related macular degeneration. Fixed versus as needed dosing 66
Intravitreal Aflibercept for Choroidal Neovascularization Due to Age-Related Macular Degeneration Unresponsive to Ranibizumab Therapy 65
INTRAVITREAL DEXAMETHASONE IMPLANT FOR THE TREATMENT OF DIFFUSE DIABETIC MACULAR EDEMA UNRESPONSIVE TO ANTI-VEGF THERAPY 65
AI-assisted analysis of early fluid dynamics following aflibercept 8 mg in treatment-naïve neovascular AMD 64
Does the presence of vitreo-macular adhesion influence the outcome of antivascular endothelial growth factor therapy in patients with neovascular agerelated macular degeneration? Systematic review and meta-analysis 64
Totale 11.820
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.111
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.111
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022583 0 0 21 18 25 39 54 34 18 119 134 121
2022/2023925 120 64 12 140 91 234 0 70 119 9 32 34
2023/2024323 66 22 6 8 40 35 13 28 45 21 2 37
2024/20252.079 37 121 111 87 39 79 138 87 230 193 322 635
2025/20264.191 375 506 403 448 582 275 372 124 259 336 303 208
2026/2027617 223 196 198 0 0 0 0 0 0 0 0 0
Totale 13.209